{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["11"],"submitter":["Pusatcioglu CK"],"pubmed_abstract":["<h4>Background</h4>Increased cellular iron exposure is associated with colorectal cancer (CRC) risk. Hepcidin, a liver peptide hormone, acts as the primary regulator of systemic iron status by blocking iron release from enterocytes into plasma. Concentrations are decreased during low iron status and increased during inflammation. The role of hepcidin and the factors influencing its regulation in CRC remains largely unknown. This study explored systemic and tumor level iron regulation in men with CRC.<h4>Methods</h4>The participants were 20 CRC cases and 20 healthy control subjects. Colonic tissue (adenocarcinoma [cases] healthy mucosa [controls]) was subjected to quantitative PCR (hepcidin, iron transporters and IL-6) and Perls' iron staining. Serum was analyzed using ELISA for hepcidin, i"],"journal":["Nutrition & metabolism"],"pagination":["21"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4037273"],"repository":["biostudies-literature"],"pubmed_title":["Systemic and tumor level iron regulation in men with colorectal cancer: a case control study."],"pmcid":["PMC4037273"],"pubmed_authors":["Fantuzzi G","Freels S","Clark J","Linzmeier R","Cabay RJ","Ng D","Braunschweig C","Tussing-Humphreys L","Llor X","Pusatcioglu CK","Nemeth E"],"additional_accession":[]},"is_claimable":false,"name":"Systemic and tumor level iron regulation in men with colorectal cancer: a case control study.","description":"<h4>Background</h4>Increased cellular iron exposure is associated with colorectal cancer (CRC) risk. Hepcidin, a liver peptide hormone, acts as the primary regulator of systemic iron status by blocking iron release from enterocytes into plasma. Concentrations are decreased during low iron status and increased during inflammation. The role of hepcidin and the factors influencing its regulation in CRC remains largely unknown. This study explored systemic and tumor level iron regulation in men with CRC.<h4>Methods</h4>The participants were 20 CRC cases and 20 healthy control subjects. Colonic tissue (adenocarcinoma [cases] healthy mucosa [controls]) was subjected to quantitative PCR (hepcidin, iron transporters and IL-6) and Perls' iron staining. Serum was analyzed using ELISA for hepcidin, i","dates":{"release":"2014-01-01T00:00:00Z","publication":"2014","modification":"2025-04-04T08:42:43.823Z","creation":"2019-03-27T01:29:00Z"},"accession":"S-EPMC4037273","cross_references":{"pubmed":["24872837"],"doi":["10.1186/1743-7075-11-21"]}}